COVID-19 in Patients with Chronic Lymphocytic Leukemia - What Have We Learned?
Description
BACKGROUND: Chronic lymphocytic leukemia (CLL) is a prevalent hematological malignancy (HM) characterized by inherent immunodeficiency, which is further pronounced by disease-directed therapy. The COVID-19 pandemic has had devastating outcomes, and
